IBDEI2DX ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40467,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,40468,0)
 ;;=R73.01^^159^1988^30
 ;;^UTILITY(U,$J,358.3,40468,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40468,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,40468,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,40468,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,40469,0)
 ;;=R74.8^^159^1988^1
 ;;^UTILITY(U,$J,358.3,40469,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40469,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,40469,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,40469,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,40470,0)
 ;;=R97.2^^159^1988^18
 ;;^UTILITY(U,$J,358.3,40470,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40470,1,3,0)
 ;;=3^Elevated Prostate Specific Antigen
 ;;^UTILITY(U,$J,358.3,40470,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,40470,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,40471,0)
 ;;=R03.0^^159^1988^17
 ;;^UTILITY(U,$J,358.3,40471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40471,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,40471,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,40471,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,40472,0)
 ;;=Z91.19^^159^1988^42
 ;;^UTILITY(U,$J,358.3,40472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40472,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,40472,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,40472,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,40473,0)
 ;;=E66.01^^159^1988^43
 ;;^UTILITY(U,$J,358.3,40473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40473,1,3,0)
 ;;=3^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,40473,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,40473,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,40474,0)
 ;;=H93.19^^159^1988^54
 ;;^UTILITY(U,$J,358.3,40474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40474,1,3,0)
 ;;=3^Tinnitus,Unspec Ear
 ;;^UTILITY(U,$J,358.3,40474,1,4,0)
 ;;=4^H93.19
 ;;^UTILITY(U,$J,358.3,40474,2)
 ;;=^5006967
 ;;^UTILITY(U,$J,358.3,40475,0)
 ;;=G47.00^^159^1988^31
 ;;^UTILITY(U,$J,358.3,40475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40475,1,3,0)
 ;;=3^Insomnia,Unspec
 ;;^UTILITY(U,$J,358.3,40475,1,4,0)
 ;;=4^G47.00
 ;;^UTILITY(U,$J,358.3,40475,2)
 ;;=^332924
 ;;^UTILITY(U,$J,358.3,40476,0)
 ;;=F43.10^^159^1988^47
 ;;^UTILITY(U,$J,358.3,40476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40476,1,3,0)
 ;;=3^PTSD,Unspec
 ;;^UTILITY(U,$J,358.3,40476,1,4,0)
 ;;=4^F43.10
 ;;^UTILITY(U,$J,358.3,40476,2)
 ;;=^5003570
 ;;^UTILITY(U,$J,358.3,40477,0)
 ;;=F43.11^^159^1988^45
 ;;^UTILITY(U,$J,358.3,40477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40477,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,40477,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,40477,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,40478,0)
 ;;=F43.12^^159^1988^46
 ;;^UTILITY(U,$J,358.3,40478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40478,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,40478,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,40478,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,40479,0)
 ;;=I25.119^^159^1988^5
 ;;^UTILITY(U,$J,358.3,40479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40479,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
 ;;^UTILITY(U,$J,358.3,40479,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,40479,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,40480,0)
 ;;=I25.10^^159^1988^7
 ;;^UTILITY(U,$J,358.3,40480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40480,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,40480,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,40480,2)
 ;;=^5007107
